Brief: Yumanity Therapeutics Exploring Strategic Alternatives To Enhance Shareholder Value And Announces Restructuring

Feb 17 (Reuters) - Yumanity Therapeutics Inc  YMTX.O :
    * YUMANITY THERAPEUTICS EXPLORING STRATEGIC ALTERNATIVES TO
ENHANCE SHAREHOLDER VALUE AND ANNOUNCES RESTRUCTURING
    * YUMANITY THERAPEUTICS INC - IN ADDITION, BOARD OF
DIRECTORS HAS
APPROVED A STRATEGIC RESTRUCTURING WITH OBJECTIVE OF PRESERVING
CAPITAL
    * YUMANITY THERAPEUTICS INC - AS PART OF RESTRUCTURING,
COMPANY
ANTICIPATES ELIMINATING APPROXIMATELY 60% OF ITS WORKFORCE
    * YUMANITY THERAPEUTICS INC - COMPANY ALSO EXPECTS TO INCUR
A
NON-RECURRING CHARGE OF APPROXIMATELY $0.4 MILLION IN Q1 OF 2022
RELATED TO RESTRUCTURING

Source text for Eikon:  ID:nGNX9Sscxb 
Further company coverage:  YMTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kineta

See all news